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ABSTRACT
Malawi is a global leader in the design and implementation of progressive HIV policies. However,
there continues to be substantial attrition of people living with HIV across the “cascade” of HIV
services from diagnosis to treatment, and program outcomes could improve further. Ability to
successfully implement national HIV policy, especially in rural areas, may have an impact on
consistency of service uptake. We reviewed Malawian policies and guidelines published between
2003 and 2013 relating to accessibility of adult HIV testing, prevention of mother-to-child
transmission and HIV care and treatment services using a policy extraction tool, with gaps
completed through key informant interviews. A health facility survey was conducted in six
facilities serving the population of a demographic surveillance site in rural northern Malawi to
investigate service-level policy implementation. Survey data were analyzed using descriptive
statistics. Policy implementation was assessed by comparing policy content and facility practice
using pre-deﬁned indicators covering service access: quality of care, service coordination and
patient tracking, patient support, and medical management. ART was rolled out in Malawi in
2004 and became available in the study area in 2005. In most areas, practices in the surveyed
health facilities complied with or exceeded national policy, including those designed to promote
rapid initiation onto treatment, such as free services and task-shifting for treatment initiation.
However, policy and/or practice were/was lacking in certain areas, in particular those strategies
to promote retention in HIV care (e.g., adherence monitoring and home-based care). In some
instances, though, facilities implemented alternative progressive practices aimed at improving
quality of care and encouraging adherence. While Malawi has formulated a range of progressive
policies aiming to promote rapid initiation onto ART, increased investment in policy
implementation strategies and quality service delivery, in particular to promote long-term
retention on treatment may improve outcomes further.
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Background
The scale-up of antiretroviral therapy (ART) for people
living with HIV (PLHIV) in Sub-Saharan Africa over
the past 10 years has been remarkable (Bor, Herbst,
Newell, & Barnighausen, 2013), and Malawi in particular
has substantially reduced HIV-attributable adult mor-
tality(Chihana et al., 2012; Jahn et al., 2008). In the
rural north of Malawi, where resource constraints are
particularly apparent, the all-cause mortality rate
among 15–59-year-olds fell by 32% once ART was intro-
duced, compared to the pre-ART period (Floyd et al.,
2010). This dramatic decline is the result of a successful
public sector HIV treatment program. Malawi was one of
the ﬁrst sub-Saharan countries to adopt a “public health
approach” to HIV scale-up, as promoted by the World
Health Organization to encourage rapid ART initiation
for PLHIV (Gilks et al., 2006). Despite recent improve-
ments in ART retention, substantial attrition across the
HIV diagnosis-to-treatment “cascade” of services con-
tinues to result in excess deaths among PLHIV before,
and after initiating ART (Jahn et al., 2008; Koole et al.,
2014; McGrath et al., 2010; Parrott et al., 2011; Wringe
et al., 2012; Zachariah et al., 2006).
The network for Analyzing Longitudinal Population-
based data on HIV in Africa (ALPHA) is investigating
mortality among PLHIV during the ART era, using longi-
tudinal data from 10 health and demographic surveillance
sites (HDSS) in six high prevalence countries: Kenya,
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Malawi (Karonga), South Africa, Tanzania, Uganda and
Zimbabwe. As part of this research program, a study
was conducted to understand policy and programmatic
factors that facilitate or inhibit PLHIV from accessing
and staying on treatment; aiming to investigate whether
policy implementation differences could explain vari-
ations in the distributions of deaths among PLHIV across
the diagnosis-to-treatment cascade.
Earlier work has shown that Malawi has more policies
to promote rapid progression of PHLIV through the cas-
cade than other countries (Church et al., 2015). In this
paper, we explore national HIV policy and its implemen-
tation within the Karonga HDSS in northern Malawi by
contrasting policy review ﬁndings with health facility
survey data to provide rich contextual analysis of HIV
policy implementation in this setting.
Methods
Study setting
By 2012, there were approximately 950,000 adults aged
>15 living with HIV in Malawi (UNAIDS, 2012),
corresponding to an adult prevalence of 10.8% (National
Statistics Ofﬁce (NSO), 2011). There were 724 static and
188 outreach testing sites, and 707 static ART sites in
mid-2014 (Ministry of Health Malawi, 2014a). By Sep-
tember 2014, an estimated 521,319 adult patients were
alive and on ART, and 78% of adults initiating ART
were retained in care one year later (Ministry of Health
Malawi, 2014a).
The HDSS was established in 2002 in Karonga District,
and has conducted HIV serosurveys since 2005. The site is
located in a rural area of 135 km2, with a population of
approximately 37,500. HIV prevalence in the HDSS was
estimated at 7% of men and 9% of women in 2012
(Floyd et al., 2012). Free ART became available in Kar-
onga district in 2005, and within the HDSS in 2006.
Policy review
We applied a policy framework developed by Church et al.
(2015; Figure 1), devised by reviewing WHO policies/
guidelines and the literature, with expert review by a
group of HIV researchers and clinicians. The framework
Figure 1. Conceptual framework of policy and service factors inﬂuencing adult mortality across the diagnosis-to-treatment cascade.
Reproduced from Church et al. (2015).
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includes 54 indicators describing service coverage and
access, quality of care, coordination of care and patient
tracking, support to PLHIV and medical management.
We reviewed all national Malawian policies and guide-
lines published between January 2003 and June 2013 on
adult HIV testing and counseling (HTC), prevention of
mother-to-child transmission services (PMTCT), and
HIV care and treatment. Eighteen documents were
reviewed (policy statements, clinical guidelines, training
manuals and strategies), and policy information was sys-
tematically extracted into an Excel tool, noting policy con-
tent, source, year of policy, and changes between 2003 and
2013. Policy data were then synthesized into a series of
indicators categorized according to whether they were:
(i) explicit; (ii) implicit or with caveats or exceptions;
(iii) unclear or conﬂicted with other policies; or (iv) no
policy in this area. Further details on this process are pro-
vided elsewhere (Church et al., 2015).
KI interviews
Three semi-structured interviews with key informants
(KI) from the National AIDS Commission, the Ministry
of Health HIV/AIDS unit, and a researcher/clinician
working on HIV/AIDS at an NGO were conducted to
ﬁll in gaps in the document review. KI also provided
their views on policy implementation, and these insights
helped to shed light on the reality of service delivery.
Interviews were audio-recorded, and notes were taken.
Facility survey
A structured questionnaire was designed to investigate
implementation of policy in adult HTC, PMTCT, and
HIV care and treatment. The survey was conducted
in December 2013 in all six facilities with catchment
areas within the Karonga HDSS that provided HIV
treatment services (n = 5), or community support and
HTC services (n = 1) (Figure 2). Of the ﬁve facilities
providing HIV treatment, one was a rural hospital,
and four were rural health centers. A nurse interviewer
conducted the group interviews in English with the
Ofﬁcer-in-charge and other healthcare providers
involved with HIV services at each health facility. Par-
ticipants gave informed consent, and interviews took
around 90 minutes.
Figure 2. Karonga HDSS and location of health facilities. Copyright Malawi Epidemiology and Intervention Research Unit. Permission to
reproduce has been given.
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Ethical approval for the facility survey was granted by
the Malawi National Health Sciences Research Commit-
tee. The facility survey data were analyzed descriptively
using Stata 12 according to the same 54 indicators that
were assessed for the policy review.
Results
The national policy response to the HIV epidemic
in Malawi
There have been two points of major change in HIV
care and treatment in Malawi. The public sector rollout
of the ART program in 2004 was groundbreaking,
bringing the potential for wide-scale delivery, and the
landscape of HIV treatment changed completely.
Prior to this, there was ad hoc small-scale private treat-
ment conﬁned to major cities and mostly delivered by
non-governmental organizations to a few patients
(NAC Ministry of Health Malawi, 2005). The “public
health approach” meant patients initiating ART did
not require CD4 counts, virology or other laboratory
tests, with eligibility assessment based on clinical
screening only; those assessed as being in WHO Clini-
cal Stage 3 or 4 were eligible to receive ART.
A second major change in the provision of HIV ser-
vices occurred in 2011 when the 1st edition of the
“Malawi Guidelines for Clinical Management of HIV
in Children and Adults” was compiled (Ministry of
Health Malawi, 2011). This focused on improving access
to PMTCT and ART, including the introduction of the
“Option B+” policy in 2011, which recommended that
all HIV-positive pregnant or breastfeeding women
initiate lifelong ART following diagnosis. Malawi was
the ﬁrst country in sub-Saharan Africa to adopt this pol-
icy, even before WHO recommended it in 2012 (World
Health Organization, 2012).
The 2011 guidelines also brought in CD4 testing, and
indicated for the ﬁrst time that ART should be initiated
for patients withWHO clinical stages 1 and 2, if they also
had a CD4 count below 350 cells/mm3. Stavudine was
phased out and policy recommended tenofovir/lamivu-
dine/efavirenz for new patients, starting with TB patients
and pregnant women, and those with lipodystrophy
(Ministry of Health Malawi, 2011).
HIV policy implementation
There were 2–6 participants per interview group in the
facility survey. Respondents included: clinical ofﬁcers,
nurse midwives, medical assistants and HTC counselors.
Tables 1–3 present information on the indicators, and
describe how policies are being implemented in the six
facilities, with regard to HTC, HIV care and treatment,
and retention in care.
Practice complies with policy guidelines, fully or
partially
For some indicators, practice complied with national
policies. For example, in all surveyed facilities, free
HTC (Table 1), PMTCT and ART (Table 2) services
were reported. Individual, group and couple pre-test
counseling is conducted in most facilities, which aligns
with policy (Table 1). Provision of free HIV services
was not restricted to government facilities: service-level
agreements with faith-based facilities extended coverage
of free HIV care, in line with policy (Tables 1 and 2).
PMTCT is available at all ﬁve antenatal care (ANC)
facilities (Table 2). Quality of care reviews are routinely
conducted (Tables 1 and 3), although it was not clear
whether these were as comprehensive as policy indicated
(Table 3). No laboratory tests were required for PLHIV
to initiate ART, in line with policy.
Policies to promote rapid initiation were
implemented including task sharing to nurses and medi-
cal assistants, and rollout of ART initiation to all facilities
(Table 2), thus making treatment rapidly accessible for
many more people. All facilities offered isoniazid preven-
tive therapy (IPT) in the pre-ART phase, and all had Iso-
niazid in stock at the time of survey (Table 3). All
facilities provided some form of counseling following
signs of poor adherence (Table 3) (pill counts and active
dialogue are supposed to be employed to identify signs of
poor adherence).
In some instances, policy was only partially
implemented. For example, while provider-initiated test-
ing and counseling (PITC) was national policy, and all
facilities with ANC offered it to pregnant women, only
four facilities routinely offered HTC to other groups (e.
g., out-patients, TB and family planning clients), and
four facilities only offered “opt-in” testing (Table 1).
ART initiation through Option B+ policy was
implemented in 4/5 facilities offering ART (Table 2),
and ART patients were given two-monthly drug supplies
once stable, not three as indicated by the policy (Table 3).
Variations across facilities were observed in procedures
following missed visits, treatment defaults and TB
screening, and the number of ﬁrst-line regimens offered
also varied (Table 3).
Policy not implemented, or unclear
Indicators of practice not adhering to policy included:
infringement of anonymous HIV testing by recording
names in registers (Table 1); referral of HIV-positive
4 A. N. Z. DASGUPTA ET AL.
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Table 1. Access to HIV testing and counseling.
Policy indicator
Year of WHO
guideline Malawi policy
Malawi practice: (i) Karonga HDSS facilities implementation, N = 6 offering HIV
testing (number of facilities in parentheses) and (ii) insights from KIs
Service coverage and access factors
Free testing at public facilities 2003 implied HTC, as a service of the Essential Health Package, should be provided free of
charge in public-sector facilities and in stand-alone sites (Ministry of Health
Malawi, 2006b). CHAM/private facilities liaise with DHO to get testing kits
and they do not charge a service fee, although they might charge a
consultation fee. If the DHO runs out and the private facility has to buy them
elsewhere, there would be a charge to the patient.a
Complies: In all 6 facilities, services reported as free for patients, including
clinic registration fee, HIV test fee, equipment fees.
Provider-initiated testing and counseling
(PITC) is standard for all clients including
at ANC
2004 Health providers are asked to ascertain HIV status for all patients attending
health services (PITC). Patients in ANC are especially encouraged for HTC,
due to the Option B+ policy (Ministry of Health Malawi, 2011). The PITC
concept was there at the beginning and started with ANC mothers.a
Partial: All 5 facilities offering ANC, offer PITC. 4 out of 5 facilities offer PITC to
OPD, TB, and STI/FP clients. However, 4 facilities noted it was “opt-in” rather
than “opt-out” testing.
Testing targeted at high-risk groups (e.g.,
sex workers, men who have sex with
men, injecting drug users)
2004 No speciﬁc policy on groups such as MSM, IDU, sex workers. The lack of policy
on targeting MSM/sex workers contrasts with a long section on targeting
testing to the deaf, dumb and visually impaired (Ministry of Health Malawi,
2006b)
Unclear: Testing services are “offered” (note, not “targeted”) to: sex workers
(5), MSM (0), drug users (3), prisoners (1), truck drivers (3), factory/estate
workers (1). Some moonlight testing takes place, where mobile clinics target
sex workers/truck drivers in hot spots.a
Parental consent not required for youth
testing (<18)
2007 When any person aged 13+ is requesting HTC, they should be considered
mature enough to give full and informed consent. Youth aged between 9
and 12 years and are sexually active should be regarded as mature minors
and considered eligible to give consent for HTC. The HTC counselor should
make an assessment of their readiness for HTC services. HTC for youth below
13 years of age should be done with the knowledge of their parents/
guardians, unless this is not possible and the testing is for provision of
treatment and care services.
Complies: Testing services are offered to schoolchildren in six facilities.
Quality of care factors
Anonymous HIV testing No names recorded in HTC register. However, ART, TB, and ANC registers have
names and HIV test results. For in-patients, the test result is documented in
in-patient notes. All patient cards and clinic registers are the property of the
Ministry of Health (MoH) and may only be kept at the respective facility or at
the National Archives. They must be kept in a locked room and only accessed
by clinic staff responsible for providing the respective service and by the
national supervision team (Ministry of Health Malawi, 2011).
Not implemented: All facilities report they record patient HIV test data in
registers/logbooks. One facility also records on patient-retained cards. The
data collected are: sex, age/DOB, residence, name and test result.
Counselor counsels 15 clients/day max Not speciﬁed Unclear: 3 facilities reported there is no maximum. 2 facilities reported max
8. 1 facility reported max 10.
Periodic refresher training for counselors
required
2001 onwards.
No frequency
No clear guidelines. No new counselors are being recruited until refreshers
have been done for all HTC counselors. This is because there were concerns
over quality of service, so refresher trainings were prioritized.a
Exceeds: 26 medical staff (doctors, clinical ofﬁcers, nurses, trained counselors)
provided HTC services. Out of these, 23 received formal training in HIV testing
within the past 2 years.
Periodic quality control checks at testing
sites required
2005. No
frequency
Activities to maintain and strengthen quality of HTC services include an internal
and external quality assurance for rapid HIV testing by laboratory technologist
and proper documentation and dissemination of QA procedures and protocols
to testing service providers, mentorship and supervision of services, client
satisfaction surveys, mystery client surveys, awards/prizes/rewards, centers of
HTC excellence etc. (Ministry of Health Malawi, 2006b)
Complies: Quality of care reviews/audits of HIV testing are conducted once
every 3 months (3 facilities), once a month (2), and once a year (1).
Coordination of care and patient tracking factors
Negatives retest every 6–12 months 2007 Re-testing every 6–12 months is beneﬁcial for individuals at higher risk of HIV
infections, e.g., persons with a history of STI, sex workers and their clients,
and sexual partners of PLHIV (Ministry of Health Malawi, 2009). The policy
might change such that low-risk people (repeat HIV-) can leave a longer
space between each test (economizing use of test resources).a
Unclear: People who test HIV negative are advised to test again in 3 months (3
facilities), or test when they feel worried (3 facilities). It is unclear if the
window period was misinterpreted as repeat testing, but if so, this is more
frequent than policy. Testing when worried is ambiguous.
(Continued )
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pregnant women from ANC to the ART clinic during
pregnancy in spite of clear guidance since 2012 that
women should initiate and be maintained on treatment
within ANC until after delivery (Table 2); low provision
of refresher training for HIV care providers (Table 3);
limited diligence in investigating adherence (Table 3).
While all facilities did report pill counts to monitor
adherence, the failure to ask patients speciﬁcally about
pill-taking suggests that the move towards an “active dia-
logue” as outlined in the policy was absent.
Practice exceeds policy guidelines
Although Malawi had policy gaps in relation to ART
registration, adherence and quality of care, the facility
surveys demonstrated that there were often alternative
practices being implemented, which focused on adher-
ence and quality of care. For example, although there
was no clear policy guidance on referral procedures to
link diagnosed clients with ART sites, facilities reported
a range of strategies to track patients’ post-diagnosis and
ensure registration in HIV care services. Five facilities
reported documentation of referral in patient notes,
three provided referral letters to patients, two completed
registers/logbooks, and one used a referral form. Fur-
thermore, three facilities reported checking HIV care
registers to ensure that registration occurred. A health-
care worker accompanied clients to the ART unit in
two of the facilities to ensure registration (Table 2).
Similarly, while there were policy gaps regarding
home-based care and peer support, other policies and
practices may have compensated for this. For example,
Malawi policy indicates that patients must have follow-
up counseling following signs of poor adherence, and
be given clear practical advice (Table 3). Policy docu-
ments also stated that patients should be asked to con-
sent to active follow-up at the time of initiating ART.
Facilities themselves also took the initiative in this area;
three reported support groups for PLHIV in the commu-
nity, and all ﬁve reported home-based care was provided
either by them, another facility, or at the community
level, although these programs were small scale and
dependent on local circumstances.
While there was no speciﬁc national policy on tar-
geted testing of high-risk groups, most facilities offered
testing to some groups, notably sex workers. A key infor-
mant also noted that mobile clinics targeted sex workers
and truck drivers in hot spots. Clinics had also preceded
national policy in the delivery of ﬁrst-line ART regimens.
At the time of the survey, national policy stipulated D4
T/3TC/NVP (Stavudne/Lamivudine/Nevirapine) pro-
vision, yet all ﬁve facilities with ART were already deli-
vering a tenofovir-based regimen (made available dueTa
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Table 2. Access to HIV care and treatment.
Policy indicator
Year of WHO
guideline Malawi policy
Malawi practice (i) Karonga HDSS facilities implementation, N = 5 offering
PMTCT and ART (number of facilities in parentheses) and (ii) insights from KIs.
Service coverage and access factors
Free PMTCT at public facilities “Universal access” PMTCT free at government facilities. Service-level agreements between MoH
and CHAM makes it free of charge at CHAM.
Complies: All 5 facilities do not charge anything for PMTCT services (clinic
registration, service fee, drugs, equipment). In practice, patients may have to
pay a prescription fee at CHAM facilities, but they are not supposed to.a
Free ART at public facilities “Universal access” ART to be provided free at point of delivery in public sector and CHAM to
eligible persons (Ministry of Health Malawi, 2006a, 2006c). In private sector,
ARV drugs will be subsidized, with patients paying roughly equivalent of
US $4 (NAC Ministry of Health Malawi, 2005). Delivery of ART through private
sector is to take load from public sector, thereby allowing it to concentrate
on the free system.
Complies: All 5 facilities do not charge for HIV care and treatment services,
including clinic registration, HIV care and treatment service fee, fees for drugs,
equipment fees, laboratory tests.
PMTCT available at all ANC facilities 2010 In ANC, there should be a range of PMTCT activities including HTC for mother,
siblings and partners, dispensing of ARVs for mother and baby, CD4 count
and staging (Ministry of Health Malawi, 2010),
Complies: All 5 facilities providing ANC also provide PMTCT services.
Clinical ofﬁcers, medical assistants
and/or nurses initiate ART
All certiﬁed clinical PMTCT/ART providers are authorized to initiate, prescribe
and dispense ART (doctors, clinical ofﬁcers, medical assistants, registered
nurses, nurse/midwife technicians). They need to have (a) attended a pre-
service ART training module and passed the ﬁnal exam, or (b) attended an
ART training course recognized by MoH, Medical Council of Malawi and
Nursing Council of Malawi and passed an exam (Ministry of Health Malawi,
2008).
Complies: All 5 facilities have nurses that can initiate. 3 facilities have clinical
ofﬁcers that can initiate. 1 facility has a medical assistant that can initiate.
All sites providing ART also initiate
ART
All sites that provide ART also initiate ART. Facilities only provided with ARV
drugs if formally assessed by MoH as ready to deliver ART. Readiness criteria
include (a) plans for recruitment and follow-up of patients, (b) functioning
CT services (c) dedicated room for ART delivery, equipped and has
monitoring tools and copies of guidelines (d) trained staff and (e) secure
storage for ARV drugs.
Complies: All 5 facilities providing ART also initiate ART.
Coordination of care and patient tracking factors
HIV-positive clients followed-up to
ensure registration at treatment site
2004 No clear follow-up policy. Counselors should have a directory of HIV-related
prevention, treatment, care and support services available for clients in
catchment area. Patients’ HIV test results and names will be documented for
such referrals (Ministry of Health Malawi, 2009).
Exceeds: Referral to HIV care and treatment services is documented in (a)
patient notes (5 facilities), (b) recorded on a referral form (1), (c) referral letter
with patient (3), register/logbook (2). Three facilities check if the HIV-positive
patients register in HIV care/treatment services. Internal referrals (pre-ART,
monitoring, ART initiation, ART resupply) are documented by register/logbook
(3), referral letter (2), facility-held patient cards/notes (2), patient-retained
cards (3).
Clear guidance on when HIV+
pregnant women be referred to ART
clinic
2006 At the time of change to Option B+ (mid-2011), it was left to sites to decide
whether to refer women to ART or to continue treatment in ANC, that is, no
clear guidelines. In mid-2012, the MoH took stock of retention and found
that the model of referral to ART did not work. New guidance stated that
ART initiation and follow-up during pregnancy should be in ANC. After
delivery, referral to ART still varies.
Unclear: Referral to ART clinics from ANC occurs in 3 facilities. Referral after
delivery, and referral on the same day, occurs in 1 facility each, respectively. 4
facilities report that a health worker accompanies the woman to ART provider/
unit. One facility reports sending the woman to ART provider/unit by herself.
Many keep providing ART to women post-partum up to 6 months before
referral to ART.a
6 monthly CD4 testing in pre-ART with
CD4<500
Repeat CD4 counts for patients over 5 years in pre-ART follow-up every 6
months. Move to 3-monthly CD4 counts if last count was less than 500. Stop
CD4 monitoring once patient is eligible for ART (Ministry of Health Malawi,
2011).
No data in facility survey.
(Continued )
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Table 2. Continued.
Policy indicator
Year of WHO
guideline Malawi policy
Malawi practice (i) Karonga HDSS facilities implementation, N = 5 offering
PMTCT and ART (number of facilities in parentheses) and (ii) insights from KIs.
Medical management factors
WHO “Option B+” is standard (2012)
(all HIV+ pregnant women initiate
life-long ART)
2012 Option B+ since July 2011. TDF + 3TC (or FTC) + EFV (Ministry of Health
Malawi, 2011).
Partial: 4 facilities reported that all HIV+ pregnant women initiate. Regimen is
TDF/3TC/EFV, for life. 3 facilities provide treatment in same building as ANC
but different room. 2 facilities provide in same facility as ANC but different
building. All facilities provide treatment on same day as ANC services.
All patients with TB eligible for ART
initiation
2009 Since the beginning of the program, Malawi made TB a stage 3 condition. It
was not a WHO stage 3 condition, so Malawi went beyond WHO guidelines,
and now WHO have followed.a
See cell below.
Co-infected TB/HIV should initiate ART
on same day or within 2 weeks of
starting TB treatment
2013 (ASAP within
8 weeks)
Initiate ART (regimen 5A) within 14 days of diagnosis of active TB. TBT and ART
can be started on the same day if patient is stable. (Ministry of Health
Malawi, 2011). There was not clear guidance on timing prior to 2011. It was
reasonable to start around the end of intensive phase of TB treatment
(around 2 months) in order to avoid drug interactions.
Partial: 4 facilities say that TB medication and ART can be initiated together,
when patients present with TB.
Initiate ART at WHO stage 3/4; or 1/2
with CD4<=350
2009 Initiate ART when WHO stage 1/2 and CD4≤ 350, or, WHO stage 3 or 4,
regardless of CD4 count (Ministry of Health Malawi, 2011). Prior to 2011, it
was a CD4 count of <250.
Partial: All 5 facilities said they’d initiate ART if clinical stage 3 or 4. 4 facilities
said they’d initiate ART if CD4 count<350.
Initiate ART within 7 days of ART
eligibility
Patients who are clinically stable should start ART no later than 7 days after
being found eligible (Ministry of Health Malawi, 2011).
Unclear: 3 facilities said 2 separate visits to the clinic are required between ART
eligibility and receiving ART drugs. 2 facilities said 1 visit is required. No time
periods speciﬁed.
Lab tests not required to start ART (e.
g., FBC, LFTS/RFTS)
Strongly
recommended
Just clinical staging and CD4 testing, are needed (and a conﬁrmatory HIV
antibody test to rule out any possibility of mix-up of test results or fraudulent
access to ART). FBC/LFTS/RFTS not required.
Complies: All 5 facilities reported that LFT, RFT, FBC are not required before a
patient can initiate ART at this facility.
Adherence counseling not
compulsory before ART initiation
Strongly
recommended
All patients must receive (a) individual counseling at ART initiation and (b)
group counseling 0–5 days before day of initiation. Option B+ women who
start ART on same day are allowed to have counseling on a later day.
Partial: Before initiating ART, 4 facilities require at least 2 adherence counseling
sessions, and one facility requires at least 1 adherence counseling session.
TDF = tenofovir, FTC = emtricitabine, EFV = efavirenz, FBC = Full blood count, QA = quality assurance.
aSource: Key informant interview.
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Table 3. Factors inﬂuencing retention in care.
Policy Indicator WHO Malawi policy
Malawi practice: (i) Karonga HDSS facilities implementation, N = 5, and (ii) insights
from KIsa
Service coverage and access factors
ART clinic does not have to
include doctor or clinical
ofﬁcer
Minimum staff requirement includes 1 clinician (2006) (Ministry of Health Malawi, 2006a) Partial: All 5 sites had at least one clinical ofﬁcer or medical assistant
Quality of care factors
Periodic refresher training for
ART staff required
2010 1-day ART classroom refresher training course to be taken once a year, followed by 1-day
knowledge dissemination and best practice. To be organized at regional/zonal level
(2006) (Ministry of Health Malawi, 2006b)
Not implemented: Out of a total of 43 staff, 15 had received formal medical/nursing
training in HIV care and treatment in the past 2 years.
Periodic quality control
checks at ART clinics
required
2010 Team of experienced clinicians to go to every ART site every quarter, as supervision. They
create a list of action points to be followed up. The form has a trigger to call a
mentoring team, in case of problems. A certiﬁcate of excellence – motivation system –
is awarded to “good” sites.a
Complies: 4 out of 4 facilities said quality of care reviews / audits of HIV treatment
services were conducted every 3 months. However, the nature of “quality of care
review” is not known, nor whether it is as comprehensive as policy demands.
Coordination of care and patient tracking factors
Routine 6 monthly CD4 count
monitoring on ART
Not a
requisite
Routine scheduled CD4 monitoring of patients on ART is not supported by the national
program (2011), to prioritize pre-ART follow up (Ministry of Health Malawi, 2011).
Previously, it was recommended if capacity was there. But this led to limited capacity
being used by a handful of sites with no tangible impact.
Partial: Two facilities conduct no CD4 tests once stabilized on ART. Two facilities report
conducting them every 6 months. One facility does not do CD4 test routinely, but
“done if requested”.
3 monthly drug supplies once
stable on ART
Patients initiating 1st line ART reviewed after 2 weeks, then every month for ﬁrst 6
months. Thereafter, stable and adherent patients can be given up to 3 months. In
exceptional cases, up to 12 months of ARVs can be dispensed. Patients starting 2nd
line ART must be seen every 4 weeks for ﬁrst 6 months, thereafter, up to 2-month
appointments. (2011) (Ministry of Health Malawi, 2011)
Partial: All 5 facilities said patients must return for reﬁlls every 2 months max, once
they stabilize on ART
Pill counts at every visit The emphasis was previously on the pill count (Ministry of Health Malawi, 2003). Now,
the focus is on a formal active dialog (including an assessment and counseling). Ask
“Have you had any problems taking your ARVs? Were there any days when you did not
manage to take all your tablets at the right time?” Check “Next appointment date” on
patient card to conﬁrm patient is not late. (Ministry of Health Malawi, 2011)
Not implemented: All facilities check and count patients’ pillbox. Only two facilities
also ask patients about pill-taking.
Home visits following signs of
poor adherence
No policy regarding home visits. However, conduct follow-up group counseling and
individual counseling if any sign of poor adherence. Give practical advice: (a) build
ARVs into daily routine, (b) ask family or friends for reminders, (c) set a daily alarm on
cell phones and (d) keep a “drug diary” and mark every tablet taken. (Ministry of
Health Malawi, 2011)
Complies: For patients who present with low drug adherence, 1 facility insists on
participation in support groups, and all 5 facilities provide psycho-social counseling.
Home visit or telephone
contact for missed visits
2013 Patients late for ART appointment to be actively followed from the clinic (home visit,
phone, guardian). Patients asked for consent for active follow-up at time of initiating
ART (can withdraw consent any time). Prioritize patients on ART and HCC patients
eligible to start ART. (2011) (Ministry of Health Malawi, 2011)
Partial: For patients that default, one facility does nothing, 3 facilities try to reach the
patient by phone and 4 report to do home visits. For patients that are lost to follow
up, 2 facilities do nothing, 2 facilities visit at home (1 missing).
Medical management factors
IPT for all HIV+ patients
without active TB
2010 Give IPT to all HIV infected who are not on ART, regardless of clinical stage/CD4 count,
who don’t have active TB. Start at enrollment for pre-ART follow-up and continue for
as long as patient is in pre-ART follow-up. Stop IPT when ART is started (2011) (Ministry
of Health Malawi, 2011).
Complies: All facilities offered IPT in pre-ART phase, and all currently had IPT in stock.
TB screening at every pre-ART
and ART visit
2010 Yes. Screen all patients at every visit (pre-ART and ART) for signs of active TB using 4
standard questions (cough, fever, night sweats, weight loss/failure to thrive). If 1+
signs, thoroughly investigate further (2011) (Ministry of Health Malawi, 2011)
Partial: 3 out of 5 facilities screen for TB for all patients initiating ART. For those that
don’t they would screen based on clinical symptoms of TB. Patients on ART are
screened for TB in 4 out of 5 facilities.
WHO 1st line ART as standard 2010 D4T/3TC/NVP (Ministry of Health Malawi, 2011). But plans to switch. Exceeds: All facilities providing TDF+3TC+EFV
At least four 1st line regimens
choices in national
programs
2006 There are 6 different 1st line regimens. 3 are used for initiating ART. All are ﬁxed-dose
combinations (only 1 type of tablet). Move patients with signiﬁcant side effects to an
alternative 1st line regimen. (2011) (Ministry of Health Malawi, 2011)
Partial: Variable. Number of different regimens in 4 of the facilities: 2, 2, 4, 6. Missing
data for 5th.
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to the Option B+ policy for pregnant or breastfeeding
women), which subsequently became policy for all
adults.
Discussion
Our policy review demonstrates that the Malawian gov-
ernment has taken a groundbreaking public health
approach to developing national HIV policies in order
to encourage as many PLHIV as possible to access and
adhere to treatment. Furthermore, these policies cover-
ing testing, PMTCT and retention in HIV care have gen-
erally been successfully implemented in facilities in this
poor, rural and remote setting. However, despite a gen-
eral picture of successful implementation, we documen-
ted several areas of disconnect between policy and
practice that are likely to contribute to attrition along
the diagnosis-to-treatment cascade, and attention to
these could improve retention in care.
For example, the observation that healthcare provi-
ders continued to rely on the pill count rather than
engage in active dialogue with the patient is concerning,
although likely explained by the additional workload and
lack of complex provider skills. Furthermore, as the
MoH had identiﬁed that immediate referral from ANC
to ART for pregnant women was not effective, the fact
that several facilities continued to make this referral as
soon as pregnant women were found to be positive
could explain why some drop out of care. A separate
analysis found that shortly after Option B+ implemen-
tation, almost half of HIV-positive pregnant women in
the HDSS and not already on ART when they became
pregnant had not initiated lifelong ART by the time of
delivery (Price, 2014). Similarly, there was lower reten-
tion in care among women initiated on ART because
of Option B+, compared to women of childbearing age
initiated on ART because of clinical or CD4 cell count
criteria (Koole et al., 2014).
In some instances, failure to comply with national
policy may have contributed to improved rates of linkage
to care. For example, while an anonymous HIV testing
policy may have been designed to reduce stigma and
fear of disclosure, recording names in HIV testing regis-
ters may promote patient tracking, identiﬁcation and
entry into care. An unexpected ﬁnding in this study
was the discovery that several health facilities were
implementing activities that went beyond national pol-
icies. For example, we documented good referral services
from HTC and ANC services to the ART clinic in the
facility survey, despite a lack of policies on linking posi-
tive individuals from testing services to HIV care and
treatment. It has been shown that progression from
HTC to ART is comparatively fast (Reniers et al.,Ta
bl
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2015), and this is likely due to these enhanced pro-
cedures, although it may also reﬂect the exposure of
this population to the HIV serological surveys which
include opportunities for HIV testing and referrals.
Our analysis has indicated that many of Malawi’s pro-
gressive policies are implemented, for example, most
women initiate ART in line with the Option B+ policy,
although their impacts on retention and mortality
remain uncertain. For example, Option B+ resulted in
a 49% increase in ART coverage among HIV-infected
pregnant women in 18 months (Tippett Barr, 2013),
but treatment default rates among pregnant or breast-
feeding women are higher than among non-pregnant
women, with Option B+ patients ﬁve times more likely
to never return after their initial clinic visit than
women starting ART with advanced disease progression
(Tenthani et al., 2014). These ﬁndings suggest that
further research is needed to investigate the impact of
Option B+ policy implementation on adherence, drug
resistance rates, and mortality.
Since the policy review was conducted, a second edi-
tion of the Malawi Guidelines for the Clinical Manage-
ment of HIV in Children and Adults was published in
April 2014. These took a new direction with emphasis
on better monitoring using viral load testing, to improve
identiﬁcation of treatment failure and ensure timely
initiation of second-line treatments and further
improved quality of care. These guidelines also indicated
that ART should be initiated in adults with CD4 counts
<500 (Ministry of Health Malawi, 2014b) even in the
absence of AIDS-deﬁning illnesses, moving closer to a
test-and-treat approach.
The approach taken in this work, drawing on qualitat-
ive policy data, quantitative facility survey data, and
interviews with key informants, has helped to inform
review of HIV policy and its implementation. This
model may be useful in other settings. Similar analyses
are being conducted in other ALPHA sites as well as a
review across countries (Church et al., 2015). Findings
have been shared with the Malawi Ministry of Health
HIV Unit (through author SM) and Karonga District
Health Ofﬁce (through author CS).
There are certain limitations to this analysis that must
be considered. Firstly, the facility surveys only covered
six facilities in a small area in northeast Malawi, and
therefore our ﬁndings are not representative of the
whole country. Certain ﬁndings from the facility survey
were, however, supported by our KI interviews,
suggesting that the ﬁndings from the facility survey are
not unique to the study area. In this respect, KIs bridged
the information between policy (from the review) and
practice (from facilities) as they had insights to share
on both.
Secondly, healthcare providers may have thought that
they were being audited and presented their work and
facility in an optimal light. Despite an explicit introduction
by the interviewers, respondents may have thought that
they should answer what is supposed to happen according
to their own training, rather than what happens in reality.
We tried to limit this by providing detailed information on
the purpose of the study, and stressing the anonymity of
the results before carrying out the interviews.
Finally, no data were collected from patient inter-
views. Patients’ experiences of implementation are likely
to vary and differ from provider reports. Our KIs
suggested, for example, that patients may be charged pre-
scription fees, which was not reported in our surveys.
Qualitative interviews with PLHIV across the cascade
are being conducted to better understand their perspec-
tives on HIV service delivery and how different policies
inﬂuence care-seeking behavior. Future analyses should
also quantify which policies and practices are most effec-
tive in improving retention in care and reducing mor-
tality, by incorporating mortality data among HIV-
infected persons in this setting.
This analysis demonstrates where national policies are
being implemented in health facilities in northern Malawi;
and identiﬁes policy implementation gaps as well as where
practices exceed national recommendations. Addressing
areas of shortfall, while reinforcing areas of excellence,
could improve retention across the diagnosis-to-treatment
cascade and reduce mortality among PLHIV.
Addendum
Since the submission of this article, a viral load monitoring
plan has been launched in Malawi, together with a commit-
ment to move towards the WHO recommendation for
immediate treatment.
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